News & Insights
Stay Informed With Our Latest Updates
Explore our comprehensive collection of news and in-depth insights spanning practice areas, industries, and regions.
Client Alert July 31, 2026
Derivatives, Legislative and Regulatory Weekly Update (July 31, 2026)
From the Derivatives Practice Group: This week, the CFTC published a Notice of Proposed Rulemaking seeking public comment on affiliations …
Client Alert July 31, 2026
Delaware Court of Chancery Holds That Statutory Safe Harbor Protects PBC Directors and Revlon’s Stockholder-Value-Maximization Mandate Does Not Apply to PBCs
Once a niche corporate form, the Delaware public benefit corporation (PBC) has become an increasingly significant feature of the corporate …
Firm News July 31, 2026
Gibson Dunn Leads IMC Rare Earths IPO
Gibson Dunn represented IMC Rare Earths Ltd. in its initial public offering and listing on NYSE American.
In the Media July 31, 2026
Gibson Dunn Among Leaders in Texas Lawbook’s Corporate Deal Tracker for 1H 2026
The Texas Lawbook calls Gibson Dunn one of the “top tier of law firms that dominate the M&A stats from every angle”
Accolades July 31, 2026
Litigator of the Week Runners-Up and Shout-Outs
A team led by Gibson, Dunn & Crutcher partner Christopher Belelieu and associate Chase Weidner and Ross Aronstam & Moritz partner S. Michael Sirkin secured the rare remedy of a return of equity in-full to client Samvit Ramadurgam in a Delaware Chancery suit involving Destiny XYZ Inc.,
Client Alert July 30, 2026
False Claims Act 2026 Mid-Year Update
This update summarizes noteworthy enforcement activity from the first six months of 2026. We discuss significant federal policy and state …
In the Media July 30, 2026
Law360 Speaks With David Salant About Immigration Habeas Decision
Law360 spoke with partner David Salant about a recent victory for client Olvin Castillo Chaver, who was arrested on February 13, 2026, during a traffic stop after police found a yellow pill they asserted was cocaine.
Webcasts July 30, 2026
Webcast: Most Favored Nation Drug Pricing Reforms: Implications for Dealmaking
Join our lawyers for a recorded webcast examining the rapidly revolving Most Favored Nation (“MFN”) and drug pricing landscape and …